OR WAIT null SECS
In first official visit to India, FDA commissioner to discuss ongoing collaboration on drug programs.
FDA has announced that Commissioner Margaret A. Hamburg, MD will make her first official trip to India on Feb. 10-18 to further strengthen cooperation between the FDA and its Indian regulatory counterparts.
During the trip, which will include visits to Delhi, Cochin, and Mumbai, Hamburg will meet with Indian policy and government leaders involved in the regulation of medical and food products exported to the United States. Currently, India is the second largest provider of finished drug products and the eighth largest exporter of food products to the United States.
“The FDA’s ongoing engagement with our regulatory counterparts in India is critical to our ability to effectively promote the health and safety of American and Indian consumers,” said Commissioner Hamburg. “I look forward to enhancing our existing relationship and identifying additional opportunities for collaboration.”
The US and Indian food and drug officials share information on the conduct of clinical trials and address product safety issues that may have an impact on both American and Indian consumers. Commissioner Hamburg will also meet with industry leaders in India to discuss the importance of maintaining high-quality standards in producing goods to ensure consumers have access to safe products, FDA reports.